Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy worsens nutritional status in breast cancer patients, requiring targeted nutritional strategies.

Probiotics help reduce hair loss and increase hair growth in people with androgenic alopecia.

Certain genetic variants may increase the risk of developing PCOS.

Human hair keratin might be good for filtering out harmful substances from water.

New regenerative medicine-based therapies for hair loss look promising but need more clinical validation.

Patients with skin diseases rated psychological effects as most impactful, needing a treatment approach that addresses both mind and body.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Taurine is important for many body functions and its deficiency can cause health problems.

Some lesser-known causes of PCOS include autoimmune issues, genetic mutations, and changes in the body's microbiome.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

Genetic variations greatly affect individual metabolism and can impact health and disease risk.

Organoid technology is improving personalized medicine by better predicting drug responses and treatments.

Neuroregulation is crucial for skin wound healing and can be targeted to improve recovery.

Environmental factors affect reproductive traits by altering the SRD5A1 gene.

Severe menstrual issues in PCOS women signal higher risk for heart and metabolic problems.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

Adipose-derived stem cells show promise in treating hair loss by promoting hair regrowth and improving hair follicle function.

MicroRNAs could help assess and manage multiple chronic diseases.

Identified genes linked to male-pattern baldness may help develop new treatments.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Certain small molecules can promote hair growth by activating a cellular cleanup process called autophagy.

Korean patients with rosacea are more likely to have other health conditions.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Advanced technologies can improve understanding and monitoring of skin-brain interactions.

Androgenetic alopecia starts earlier in males than females, with different treatments, and is linked to income, education, alcohol use, and mental health.

Smoking and alcohol worsen hair transplant results.

The study found that heart disease is common in people with PCOS and that being overweight is a major risk factor; lifestyle changes and medication are important for management.

Lifestyle changes improve reproductive function and hormonal balance in obese women with PCOS.

Ayurvedic treatment improved PCOS symptoms and hormone levels.

Acne in reproductive-age women may be linked to conditions like PCOS and lifestyle factors, so doctors should check for these when treating acne.